RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Biogend Therapeutics Co Stock

Biogend Therapeutics Co Equity 2024

Biogend Therapeutics Co Equity

940.96 M TWD

Ticker

6733.TWO

ISIN

TW0006733009

In 2024, Biogend Therapeutics Co's equity was 940.96 M TWD, a 33.88% increase from the 702.86 M TWD equity in the previous year.

Biogend Therapeutics Co Aktienanalyse

What does Biogend Therapeutics Co do?

Biogend Therapeutics Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Biogend Therapeutics Co's Equity

Biogend Therapeutics Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Biogend Therapeutics Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Biogend Therapeutics Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Biogend Therapeutics Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Biogend Therapeutics Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Biogend Therapeutics Co stock

What is the equity of Biogend Therapeutics Co this year?

Biogend Therapeutics Co has equity of 940.96 M TWD this year.

What was the equity of Biogend Therapeutics Co compared to the previous year?

The equity of Biogend Therapeutics Co has increased/decreased by 33.88% increased compared to the previous year.

What impact does a high equity have on investors of Biogend Therapeutics Co?

A high equity is advantageous for investors of Biogend Therapeutics Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Biogend Therapeutics Co?

A low equity can be a risk for investors of Biogend Therapeutics Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Biogend Therapeutics Co affect the company?

An increase in equity of Biogend Therapeutics Co can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Biogend Therapeutics Co affect the company?

A reduction in equity of Biogend Therapeutics Co can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Biogend Therapeutics Co?

Some factors that can affect the equity of Biogend Therapeutics Co include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Biogend Therapeutics Co so important for investors?

The equity of Biogend Therapeutics Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Biogend Therapeutics Co take to change the equity?

To change equity, Biogend Therapeutics Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Biogend Therapeutics Co pay?

Over the past 12 months, Biogend Therapeutics Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Biogend Therapeutics Co is expected to pay a dividend of 0 TWD.

What is the dividend yield of Biogend Therapeutics Co?

The current dividend yield of Biogend Therapeutics Co is .

When does Biogend Therapeutics Co pay dividends?

Biogend Therapeutics Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Biogend Therapeutics Co?

Biogend Therapeutics Co paid dividends every year for the past 0 years.

What is the dividend of Biogend Therapeutics Co?

For the upcoming 12 months, dividends amounting to 0 TWD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Biogend Therapeutics Co located?

Biogend Therapeutics Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Biogend Therapeutics Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Biogend Therapeutics Co from 11/14/2024 amounting to 0 TWD, you needed to have the stock in your portfolio before the ex-date on 11/14/2024.

When did Biogend Therapeutics Co pay the last dividend?

The last dividend was paid out on 11/14/2024.

What was the dividend of Biogend Therapeutics Co in the year 2023?

In the year 2023, Biogend Therapeutics Co distributed 0 TWD as dividends.

In which currency does Biogend Therapeutics Co pay out the dividend?

The dividends of Biogend Therapeutics Co are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Biogend Therapeutics Co

Our stock analysis for Biogend Therapeutics Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biogend Therapeutics Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.